OverviewEngineered with versatility in mind, the AXS Vecta 46 Intermediate Catheter is intended to extend distal support in hemorrhagic and aspiration procedures, enable treatment of distal occlusions, and provide delivery support for large-bore devices.
PerformanceWith a distal flexibility profile, soft atraumatic tip and enhanced kink resistance, AXS Vecta 46 catheters provide trackability, handling and control through tortuous distal neurovascular anatomy.
CompatibilityThe low outer profile and maximized inner diameter (ID) deliver broad device compatibility and aspiration performance. Thin-wall technology and a full-length PTFE liner enable stent retriever compatibility while preserving aspiration capability.
Product features- Soft atraumatic tip — intended to advance farther distal
- Thin-wall technology — maximizes ID for device compatibility and aspiration power
- 11 cm distal flex zone with hydrophilic coating — for improved trackability
- Full-length PTFE liner — for smooth device delivery
- Full-length nitinol construction — for flexibility and kink resistance
- Three lengths available — 125 cm, 146 cm, 160 cm
Available lengths / Configurations125 cm, 146 cm, 160 cm
UPN / Description:
INC-15123-125: 125cm AXS Vecta 46 Intermediate Catheter
INC-15123-146: 146cm AXS Vecta 46 Intermediate Catheter
INC-15123-160: 160cm AXS Vecta 46 Intermediate Catheter
Product specificationsID: 0.046 in
Distal OD: 0.056 in
Proximal OD: 0.058 in
Lengths: 125 cm, 146 cm, 160 cm
Technical characteristics- Marque: Stryker
- Commercial name: AXS Vecta™ 46
- ID (inner diameter): 0.046 in
- Distal outer diameter: 0.056 in
- Proximal outer diameter: 0.058 in
- Available lengths: 125 cm, 146 cm, 160 cm
- Tip: Soft atraumatic tip
- Distal flex zone: 11 cm with hydrophilic coating
- Liner: Full-length PTFE liner
- Construction: Full-length nitinol for flexibility and kink resistance
- Technology: Thin-wall technology for maximized ID and aspiration performance
- Intended uses: distal support in hemorrhagic procedures, aspiration treatment, MeVO combination treatment and stent retriever compatibility